A new approach to malnutrition is moving away from pills and traditional supplements — and toward something far more unusual: bacteria.
The Bill & Melinda Gates Foundation has backed a startup working on what it calls a bacteria-based system to help fight malnutrition, according to reporting from Forbes’ The Prototype section.
The idea sounds unconventional at first glance, but the logic behind it is tied to a long-running problem in global health.
Malnutrition remains one of the leading underlying causes of child illness and death in poorer regions, especially in parts of sub-Saharan Africa and South Asia, where diets lack essential nutrients and immune systems are weakened as a result.
The startup, according to the report, is exploring the use of engineered or targeted bacteria to support nutrition in the human body, rather than relying only on external food-based supplements.
People familiar with early discussions around the project say the approach is aimed at “restoring balance” in the gut environment, which researchers believe plays a role in how the body absorbs nutrients.
One researcher involved in microbiome-related work linked to the Gates Foundation said the interest in bacteria-based solutions comes from a simple frustration that traditional nutrition interventions have not been enough in some regions. The person described the goal as finding “new ways to help the body actually use what it gets.”
The Gates Foundation itself has not publicly detailed every technical aspect of the funding, but it has consistently supported research into nutrition, child health, and microbiome science over the years, including work focused on how gut bacteria affects growth and immunity.
Still, the approach is not without debate.
Some public health experts argue that while microbiome-based solutions are promising, they are still in early stages and may take years before showing consistent real-world impact at scale. Others say the focus on biological innovation risks distracting from simpler issues like food access, sanitation, and poverty.
Details of clinical testing timelines and rollout plans remain limited for now, and it is not immediately clear how far along the startup’s trials are.
But the direction of interest is clear.
Rather than only treating malnutrition from the outside — through food aid or supplements — researchers are now exploring whether part of the solution might involve changing what happens inside the body itself.
And that shift raises bigger questions about where global health funding is heading next, especially as donors look for approaches that can scale beyond traditional aid systems.
For now, the idea sits somewhere between experimental science and early-stage intervention.
But it reflects a broader pattern in global health research: the search for solutions that go deeper than food alone, into the biology of how the human body responds to it.
